Patent · US Active

Polyphosphazene delivery system for inorganic nanocrystals

US10940217B2 · kind B2 · utility

1Cited by
2References
9Claims
0Family size

Assignees

Inventors

Key dates

Filing dateMar 18, 2015
Grant dateMar 9, 2021
Priority date
Expiry dateMar 18, 2035

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61N2005/1098
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Nanoclusters comprising inorganic nanocrystals and a biodegradable polymer are disclosed. The inorganic nanocrystals have a mean particle size of 1 to 500 nm. The inorganic nanocrystals are contained within a core of the nanoclusters, on the surface of the nanoclusters, contained within a core of the nanoclusters, dispersed throughout the nanoclusters, or a combination thereof. The biodegradable polymer allows the inorganic nanocrystals to be excreted renally over a period of time. The nanoclusters can be used for medical imaging or other biomedical applications.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.